Edoardo La Sala

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni et al. · Blood · 2019 · 215 citations · Full text

Medicine, Internal Medicine, Oncology +8

Temsirolimus, an mTOR inhibitor, in combination with lower‐dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML‐1107)

Sergio Amadori, Roberto Stasi, Alberto M. Martelli et al. · British Journal of Haematology · 2011 · 71 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Antenatal Diagnosis of Surgically Correctable Anomalies: Effects of Repeated Consultations on Parental Anxiety

Lucia Aite, Alessandro Trucchi, A. Nahom et al. · Journal of Perinatology · 2003 · 63 citations · Full text

Medicine, Maternal Health, Obstetrics +10

Esophagogastric dissociation versus fundoplication: Which is best for severely neurologically impaired children?

Claudia Gatti, G. Federici di Abriola, M. Trassierra Villa et al. · Journal of Pediatric Surgery · 2001 · 60 citations · Full text

Medicine, Child Health, Pediatrics +12

Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Maria Teresa Voso, Luca Guarnera, Konstanze Döhner et al. · Blood · 2024 · 40 citations

Medicine, Hematology, Oncology +8